LENZ Therapeutics Inc. (LENZ)

21.48

-0.06 (-0.28%)

At close: Mar 04, 2025, 12:50 PM

LENZ Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-124.65M	-101.05M	-70.76M	-68.37M	-109K
Depreciation & Amortization	2.41M	8.35M	734K	121K	n/a
Stock-Based Compensation	n/a	721K	196K	n/a	n/a
Other Working Capital	-36.87M	-7.4M	-4.32M	1.11M	22K
Other Non-Cash Items	71.46M	28.43M	19.32M	57.47M	92K
Deferred Income Tax	n/a	-17.22M	161K	n/a	n/a
Change in Working Capital	-39.22M	-7.21M	-2.5M	1.71M	10K
Operating Cash Flow	-90.01M	-87.98M	-52.85M	-8.72M	-19K
Capital Expenditures	-10.86M	-6.59M	-5.74M	-1.54M	n/a
Acquisitions	1.9M	n/a	n/a	n/a	n/a
Purchase of Investments	-28.13M	-405.52M	n/a	n/a	n/a
Sales Maturities Of Investments	263.43M	170.25M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	226.35M	-241.86M	-5.74M	-1.54M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-67K	-79K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	30.13M	23.07M	n/a	n/a
Financial Cash Flow	190K	597K	417.47M	30.08M	n/a
Net Cash Flow	138.13M	-329.25M	357.16M	19.81M	-19K
Free Cash Flow	-100.86M	-94.57M	-58.59M	-10.27M	-19K